SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses its adoption by Kalshi and potential for significant growth in the RWA (Real World Asset) space. Talk centers on its role in providing real-time data and the potential impact of institutional investment. Some users are comparing it to Chainlink and anticipating a price surge.

Trump For President

Trump Crypto is trending amidst community discussions about its volatile performance and potential connection to broader market events, with some users highlighting its significant decline since inception and others speculating on future rallies.  The conversation includes opinions on its association with political figures and comparisons to other cryptocurrencies. Some investors discuss its possible use during this political cycle.

WorldFinancial

WorldFinancial (WLFI) is trending amid discussions about its potential as a tokenized asset platform and its association with prominent figures. Community members are debating the coin's fundamentals, future utility, and possible price movements, with some drawing comparisons to other cryptocurrencies. Bullish sentiment centers on upcoming catalysts and the broader crypto market, while bears cite centralization and governance concerns.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending as community members discuss the possibility of a buyout, with some speculating on potential suitors and ideal acquisition prices. Positive data readouts and analyst target upgrades are also fueling optimism. However, news of a recent public offering has sparked debate about its implications for a potential deal and the company's financial strategy.

Pump.fun

$PUMP is trending amidst community excitement and discussion around its potential within the Solana meme coin ecosystem. Conversations highlight the strength and dedication of the $WAGMI community, with many expressing long-term bullish sentiment. The community is focused on weathering market fluctuations and building a strong foundation for future growth on the $SOL network.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as the biotech sector shows signs of recovery, with traders closely watching for a breakout above key resistance levels and potential catalysts. Community members are actively discussing potential FDA approvals and merger/acquisition (M&A) activity within the sector, while also weighing broader market conditions and the potential impact of tariffs. Some are noting the relative underperformance of biotech compared to other sectors, suggesting a possible catch-up rally.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne ($TER) is trending as investors anticipate upcoming earnings results and evaluate the company's potential to capitalize on AI compute demand. Community discussions revolve around whether AI-driven growth can offset potential weakness in other sectors like robotics. Recent analyst activity is mixed, with some firms adjusting price targets and ratings, reflecting uncertainty about Teradyne's near-term performance amid broader semiconductor industry dynamics.

Just a dead guy

DEADGUY is trending as the community highlights the token's contract address and increasing holder count. Some users are comparing it to other tokens, speculating on potential market cap growth. The coin is also gaining traction on platforms like Phantom Wallet.

Shibmas was launched on the 9th Of December. The project is a meme token and gives homage to Shiba Inu the token. The token is a playful character who is bringing the Christmas spirit to token holders all around the world. We plan on getting many listings on various exchanges in the coming days. We have over 1000 holders in 24 hours and we aim on getting over 10000 holders within the next week and in the run up to Christmas

Shibmas

Shibmas ($SMAS) is trending due to observed momentum and swift price movements. The crypto community is actively discussing support levels and potential follow-through, with many highlighting its availability on Phantom Wallet. Traders are monitoring $SMAS alongside other cryptocurrencies like Solana and Bitcoin.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending amid community excitement over its recent price surge and potential as a privacy-focused alternative to Bitcoin, with some drawing attention to its limited supply. Discussions include speculation about potential listings on platforms like Robinhood and comparisons to other privacy coins. An advisor to a former POTUS tweeting positively about the token appears to be a catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 PR Newswire SAN DIEGO, Feb. 13...

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update Aethlon Medical Announces Financial Results for the Fiscal Third Quarter...

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference...

Aethlon Medical Treats First Patient in Australian Hemopurifier Cancer Trial

Aethlon Medical Treats First Patient in Australian Hemopurifier Cancer Trial Aethlon Medical Treats First Patient in Australian Hemopurifier Cancer Trial PR Newswire SAN DIEGO, Jan. 29, 2025 First...

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update Aethlon Medical Announces Financial Results for the Fiscal Second...

An Overview of Aethlon Medical's Earnings

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia Aethlon Medical Reaches Key Milestone with Enrollment of the First...

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit PR Newswire SAN DIEGO, Oct. 8, 2024 SAN DIEGO...

Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India

Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India PR Newswire SAN DIEGO, Sept. 19...

Aethlon Medical to Present at Virtual Investor Conferences in September

Aethlon Medical to Present at Virtual Investor Conferences in September Aethlon Medical to Present at Virtual Investor Conferences in September PR Newswire SAN DIEGO, Sept. 17, 2024 SAN DIEGO, Sept...

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

Aethlon Medical Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$5.39
Prev Close	$5.24
Open	$5.24
Dividend Yield	0.00%
50-Day Moving Average	$9.13
Beta	0.59
Avg. Volume	98,434.25
PE Ratio	-0.08

52-Week High	$84.40
52-Week Low	$4.65
Market Capitalization	$4.1M
EPS (Annual)	-$85.78
Price to Book	0.41
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

AEMD
Aethlon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AEMD News

AEMDAethlon Medical Inc